San Diego, CA – Enlyte recently released the third portion of its Mitchell Pharmacy Solutions Drug Trends Series Report, which analyzes the state of pharmacy trends in workers’ comp.
In part three of the series, Mitchell explores trends experienced in the opioid drug category, noting that opioids continue to represent a decreasing proportion of overall scripts and costs, with favorable trends seen in important markers such as morphine equivalent dose (MED), duration of use, and access to guideline-supported measures including medication-assisted treatment (MAT) and overdose rescue medication (naloxone).
Key highlights included:
- Opioid scripts dropped 1.3% and costs were down 3.2% from 2020. While opioids continue to decline as a percentage of total script volume and costs, it remains essential to promote evidence-based risk management strategies.
- The number of injured workers using opioids has continued to decline from 33.3% of all injured workers in 2020 to 30.3% in 2021.
- More than half of the top 20 states ranked by opioid script volume experienced decreases in High MED (Scripts w/daily MED of 90 mg or above) in 2021.
- Opioid claims using Medication-Assisted Treatment (MAT) remained ﬂat through 2021, however, of those claims with MAT medications prescribed, MAT scripts increased 1.3%.
Read the free report: Mitchell Pharmacy Solutions Drug Trends Series Part 3
Enlyte is a WorkCompWire ad partner.
This is NOT a paid placement.